Allan M. Fox's most recent trade in Regenxbio Inc was a trade of 24,454 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on May 31, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 24,454 | 24,454 | - | - | Stock Options (Right to Buy) | |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 4,790 | 11,286 (0%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 17,892 | 17,892 | - | - | Stock Options (Right to Buy) | |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 3,486 | 6,496 (0%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 15,324 | 15,324 | - | - | Stock Option (Right to Buy) | |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 3,010 | 3,010 (0%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Sale of securities on an exchange or to another person at price $ 34.40 per share. | 22 Dec 2021 | 61,638 | 1,581,212 (4%) | 0% | 34.4 | 2,120,575 | Common Stock |
Regenxbio Inc | Allan M. Fox | Director | Sale of securities on an exchange or to another person at price $ 34.92 per share. | 22 Dec 2021 | 44,908 | 1,536,304 (4%) | 0% | 34.9 | 1,568,120 | Common Stock |
Regenxbio Inc | Allan M. Fox | Director | Sale of securities on an exchange or to another person at price $ 35.85 per share. | 22 Dec 2021 | 6,323 | 1,529,981 (4%) | 0% | 35.8 | 226,664 | Common Stock |
Regenxbio Inc | Allan M. Fox | Director | Sale of securities on an exchange or to another person at price $ 45.04 per share. | 17 Sep 2021 | 48,233 | 1,364,309 (3%) | 0% | 45.0 | 2,172,323 | Common Stock |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
Regenxbio Inc | Allan M. Fox | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jul 2020 | 225,000 | 225,000 (0%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jul 2020 | 225,000 | 1,414,110 (3%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jul 2020 | 90,000 | 315,000 (0%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Jul 2020 | 90,000 | 1,324,110 (3%) | 0% | 0 | Common Stock | |
Regenxbio Inc | Allan M. Fox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |